Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Carisma Therapeutics Inc. (CARM) had Free Cash Flow per Share of $-0.37 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-9.77M |
|
-- |
|
-- |
|
$5.78M |
|
$-5.78M |
|
$-4.00M |
|
$-9.77M |
|
$-6.24M |
|
$-9.77M |
|
$-9.77M |
|
$-9.77M |
|
$-6.24M |
|
$-5.78M |
|
$-5.78M |
|
41.79M |
|
41.79M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$4.29M |
|
-- |
|
$0.72M |
|
$5.01M |
|
$8.95M |
|
-- |
|
$42.07M |
|
$51.02M |
|
$-46.01M |
|
$-46.01M |
|
$-46.01M |
|
41.79M |
|
| Cash Flow Statement Financials | |
$-15.97M |
|
$0.69M |
|
$-0.63M |
|
$17.91M |
|
$2.00M |
|
$-15.91M |
|
$0.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.48 |
|
-- |
|
-- |
|
-- |
|
-0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.25% |
|
21.25% |
|
-195.01% |
|
21.25% |
|
$-1.10 |
|
|
Free Cash Flow per Share |
$-0.37 |
$-0.38 |
|